<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7362854\results\search\testTrace\results.xml">
  <result pre="physicochemical descriptors of approved and experimental drugs selected for COVID-19" exact="treatment" post="could be useful for antiviral drug optimization, drug combination"/>
  <result pre="conditions leading to multiple organ failure. In more severe cases," exact="infection" post="causes bilateral pneumonia, acute respiratory distress syndrome, kidney failure,"/>
  <result pre="date (June 04, 2020), more than 11million worldwide cases of" exact="infection" post="and 525.491 deaths have been attributed to the novel"/>
  <result pre="specific antiviral agents against SARS-CoV-2, and the current methods for" exact="treatment" post="of COVID-19 are still controversial. Fortunately, after analyzing the"/>
  <result pre="especially alveolar macrophages) involved in protection against invading antigens. This" exact="detection" post="triggers a downstream cascade of many T-cell stimulators and"/>
  <result pre="thus realizing a drug repurposing strategy [28]. As such, rapid" exact="screening" post="of safe and effective drugs available in drug libraries"/>
  <result pre="the anti-SARS-Co-V2 drug search. Most of the drugs examined for" exact="treatment" post="of this disease fall into the following drug classifications:"/>
  <result pre="drug and ii) new information on in silico molecular modeling" exact="screening" post="and inÂ vitro and inÂ vivo anti-SARS-Co-V2 activities of"/>
  <result pre="should not be considered as final conclusions or recommendations for" exact="treatment" post="or prevention and should not be covered in the"/>
  <result pre="targets do not guarantee the effectiveness of a drug in" exact="treatment" post="under clinical conditions. However, these works provide a general"/>
  <result pre="KaletraÂ®, effective drug, approved by FDA in 2001 for the" exact="treatment" post="of HIV infection in adults [52,53]. Favipiravir (T-705, AviganÂ®)"/>
  <result pre="approved by FDA in 2001 for the treatment of HIV" exact="infection" post="in adults [52,53]. Favipiravir (T-705, AviganÂ®) is a pyrazinecarboxamide"/>
  <result pre="synthetic nucleoside antiviral drug, which is approved by FDA for" exact="treatment" post="of respiratory syncytial virus and hepatitis C virus infection."/>
  <result pre="[68,69]. IngavirinÂ® is an original Russian antiviral drug for the" exact="treatment" post="and prevention of acute respiratory viral infections by influenza"/>
  <result pre="unique mechanism of action. This drug provides early recognition of" exact="infection" post="and the formation of the antiviral state of cells"/>
  <result pre="(ZithromaxÂ®) is an inexpensive semisynthetic antibiotic drug used for the" exact="treatment" post="of several bacterial infection. It was discovered 1980 and"/>
  <result pre="in combination with ritonavir, peginterferon alfa and ribavirin for the" exact="treatment" post="of treatment-naive patients with non-cirrhotic genotype 1b chronic hepatitis"/>
  <result pre="so-called â€œAIDS cocktailâ€� therapy (combination antiretroviral therapy) [85], future COVID-19" exact="treatment" post="could be based on combination drugs that impact multiple"/>
  <result pre="old magic bullets to modern â€œbinary or trinary weaponsâ€�, a" exact="treatment" post="against this coronavirus is still far away. 4 Bioavailability"/>
  <result pre="players in the immune system, which is overactive under viral" exact="infection" post="[94,95]. In this context, it is of interest to"/>
  <result pre="blocks internalization into host cells during the early phase of" exact="infection" post="(in mice). One of the most parameters of this"/>
  <result pre="RNA polymerase, is only administered intravenously, and compassionate use in" exact="treatment" post="of patients hospitalized for severe Covid-19 showed clinical improvement"/>
  <result pre="are currently in Phase III clinical trials as a possible" exact="treatment" post="for COVID-19 in the USA (remdesivir) and Japan (favipiravir)."/>
  <result pre="activity. According to recent work on control of the SARS-CoV-2" exact="infection" post="inÂ vitro, hydroxychloroquine was less toxic and more efficient"/>
  <result pre="is sufficient preclinical rationale and evidence on their effectiveness for" exact="treatment" post="of COVID-19 to validate their use in the clinic"/>
  <result pre="is a pity that information on this drug in COVID-19" exact="treatment" post="is minimally available, and its use against coronavirus is"/>
  <result pre="membrane permeability and transport properties, are important drugs in the" exact="treatment" post="of malaria as well as severe rheumatoid arthritis and"/>
  <result pre="the cytokine storm [115,116]. Another promising drug candidate for coronavirus" exact="treatment" post="is ivermectin, which is in phase III clinical trials"/>
  <result pre="protein/ACE2) and regulation of the human immune response to viral" exact="infection" post="(JAK 1/JAK 2/interleukin (IL)-1Î² and IL-6). Understanding the mechanisms"/>
  <result pre="is increasing, however this drug (approved only in USA) and" exact="treatment" post="is very expensive, perhaps due to its complicated and"/>
  <result pre="Favipiravir, an inexpensive antiviral drug, was approved for a COVID-19" exact="treatment" post="in several countries. Recently, it was found that dexamethasone"/>
  <result pre="this drug is required [145]. Therefore, the current methods for" exact="treatment" post="of COVID-19 and the criterions of drug selection are"/>
  <result pre="2019 novel coronavirus in Wuhan, ChinaLancet39510223202049750631986264 26LiX.GengM.PengY.MengL.LuS.Molecular immune pathogenesis and" exact="diagnosis" post="of COVID-19J.Â Pharm. Anal.102202010210832282863 27ContiP.RonconiG.CaraffaA.GallengaC.E.RossR.FrydasI.Induction of pro-inflammatory cytokines (IL-1"/>
  <result pre="382 Studies2020Retrieved from:https://www.cebm.net/oxford-covid-19/covid-19-registered-trials-and-analysis/ 31J. Wang, Fast identification of possible drug" exact="treatment" post="of coronavirus disease-19 (COVID-19) through computational drug repurposing study,"/>
  <result pre="for SARS-CoV-2, Drug DiscovToday Off.2552020928941 45GautretP.LagierJ.C.ParolaP.MeddebL.MailheM.DoudierB.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trialInt."/>
  <result pre="both epidemic and zoonotic coronavirusesSci. Transl. Med.93962017eaal3653 52ChandwaniA.ShuterJ.Lopinavir/ritonavir in the" exact="treatment" post="of HIV-1 infection: a reviewTherapeut. Clin. Risk Manag.45200810231033 53CroxtallJ.D.M"/>
  <result pre="show antiviral and anticancer activityMini Rev. Med. Chem.109201080682120482498 67KhaliliJ.S.ZhuH.MakA.YanY.ZhuY.Novel coronavirus" exact="treatment" post="with ribavirin: groundwork for evaluation concerning COVID-19J.Â Med. Virol.20203010.1002/jmv.25798March"/>
  <result pre="a 15-membered macrolide antibiotic, inhibits influenza A (H1N1) pdm09 virus" exact="infection" post="by interfering with virus internalization processJ.Â Antibiot.7210201975976831300721 75OheM.ShidaH.JodoS.KusunokiY.SekiM.FuruyaK.GoudarziH.Macrolide treatment"/>
  <result pre="virus infection by interfering with virus internalization processJ.Â Antibiot.7210201975976831300721 75OheM.ShidaH.JodoS.KusunokiY.SekiM.FuruyaK.GoudarziH.Macrolide" exact="treatment" post="for COVID-19: will this be the way forward?BioScience Trends142202015916032249257"/>
  <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="inÂ vitroCell Discov6120201610.1038/s41421-020-0156-032194981 107MarmorM.F.KellnerU.LaiT.Y.MellesR.B.MielerW.F.Recommendations on screening for chloroquine and"/>
  <result pre="effective in inhibiting SARS-CoV-2 infection inÂ vitroCell Discov6120201610.1038/s41421-020-0156-032194981 107MarmorM.F.KellnerU.LaiT.Y.MellesR.B.MielerW.F.Recommendations on" exact="screening" post="for chloroquine and hydroxychloroquine retinopathy (2016 revision)Ophthalmol. Times1236201613861394 108VerbaanderdC.MaesH.SchaafM.B.SukhatmeV.P.PantziarkaP.SukhatmeV.Repurposing"/>
  <result pre="review on the efficacy and safety of chloroquine for the" exact="treatment" post="of COVID-19J.Â Crit. Care202010.1016/j.jcrc.2020.03.005 112LianN.XieH.LinS.HuangJ.ZhaoJ.LinQ.Umifenovir treatment is not associated"/>
  <result pre="of chloroquine for the treatment of COVID-19J.Â Crit. Care202010.1016/j.jcrc.2020.03.005 112LianN.XieH.LinS.HuangJ.ZhaoJ.LinQ.Umifenovir" exact="treatment" post="is not associated with improved outcomes in patients with"/>
  <result pre="and projection of optimized dosing design of hydroxychloroquine for the" exact="treatment" post="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)Clin. Infect."/>
  <result pre="urgencyAm. J. Trop. Med. Hyg.102620201156115732314704 118MomekovG.MomekovaD.Ivermectin as a potential COVID-19" exact="treatment" post="from the pharmacokinetic point of viewMedRxiv202010.1101/2020.04.11.20061804 119PillaiyarT.MeenakshisundaramS.ManickamM.Recent discovery and"/>
  <result pre="its discovery and development leading to human clinical trials for" exact="treatment" post="of COVID-19Preprints202010.20944/preprints202004.0299.v12020040299 130WangY.ZhangD.DuG.DuR.ZhaoJ.JinY.Remdesivir in adults with severe COVID-19: a"/>
  <result pre="Allows For â€™Emergency Useâ€™ of RemdesivirExperimental coronavirus drugAvailable at:https://time.com/5831062/fda-allows-emergency-use-remdesivir/ 134CaiQ.YangM.LiuD.ChenJ.ShuD.XiaJ.Experimental" exact="treatment" post="with favipiravir for COVID-19: an open-label control studyEngineering202010.1016/j.eng.2020.03.007 135EkinsS.LaneT.R.MadridP.B.Tilorone:"/>
  <result pre="of a pyrrolo [2, 1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the" exact="treatment" post="of Ebola and emerging virusesJ.Â Med. Chem.60520171648166128124907 144collab: Oxford"/>
  <result pre="Agents343202010.23812/20-EDITORIAL_1-5 146MehraM.R.DesaiS.S.RuschitzkaF.PatelA.N.Hydroxychloroquine or chloroquine with or without a macrolide for" exact="treatment" post="of COVID-19: a multinational registry analysisLancet2020 147Funck-BrentanoC.SalemJ.E.Chloroquine or hydroxychloroquine"/>
 </snippets>
</snippetsTree>
